HCA Healthcare Inc (HCA) Shares Sold by Sentry Investment Management LLC

Sentry Investment Management LLC reduced its position in HCA Healthcare Inc (NYSE:HCA) by 6.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,743 shares of the company’s stock after selling 1,219 shares during the quarter. Sentry Investment Management LLC’s holdings in HCA Healthcare were worth $2,468,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of HCA. Smithfield Trust Co. raised its stake in shares of HCA Healthcare by 541.9% during the second quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock worth $102,000 after purchasing an additional 840 shares during the last quarter. Signet Financial Management LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $137,000. Adviser Investments LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $159,000. Bridgeworth LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $173,000. Finally, Hyman Charles D purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $205,000. 70.84% of the stock is owned by institutional investors and hedge funds.

In other news, SVP Jane D. Englebright sold 6,543 shares of the firm’s stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total value of $849,673.98. Following the completion of the transaction, the senior vice president now owns 7,443 shares in the company, valued at $966,547.98. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Michael S. Cuffe sold 5,196 shares of the firm’s stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total value of $709,357.92. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,486 shares of company stock valued at $3,079,086. Company insiders own 2.80% of the company’s stock.

HCA has been the subject of several analyst reports. Jefferies Financial Group restated a “buy” rating and set a $135.00 price target on shares of HCA Healthcare in a research note on Thursday, July 26th. SunTrust Banks increased their price objective on HCA Healthcare to $145.00 and gave the stock a “buy” rating in a research report on Thursday, July 26th. Cantor Fitzgerald reiterated a “buy” rating and issued a $115.00 price objective on shares of HCA Healthcare in a research report on Friday, July 20th. ValuEngine upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Finally, Zacks Investment Research upgraded HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 price objective for the company in a research report on Monday, July 16th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $141.53.

Shares of HCA stock opened at $143.95 on Friday. HCA Healthcare Inc has a fifty-two week low of $74.26 and a fifty-two week high of $144.18. The firm has a market capitalization of $48.75 billion, a PE ratio of 15.92, a PEG ratio of 1.24 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.23. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The business had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.29 billion. During the same quarter last year, the business posted $1.13 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, sell-side analysts forecast that HCA Healthcare Inc will post 9.35 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be given a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Friday, November 30th. HCA Healthcare’s dividend payout ratio is currently 21.24%.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/11/10/hca-healthcare-inc-hca-shares-sold-by-sentry-investment-management-llc.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Outstanding Shares, Buying and Selling Stocks

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply